News APRINOIA Therapeutics Announces Strategic Investment From The Alzheimer’s Drug Discovery Foundation (ADDF) Staff September 11, 2023 Iframe sync Post navigation Previous: Eledon Pharmaceuticals Appoints Industry Veteran James Robinson to its Board of DirectorsNext: Marker Therapeutics Announces Complete Response in First Lymphoma Patient Treated with MT-601 after CAR T Relapse More Stories Healthcare News Pharmaceutical Cellbxhealth PLC Announces Holding(s) in Company Staff December 23, 2025 Brain Healthcare Hospitals News Pharmaceutical MindMaze Therapeutics: Consolidating a Global Approach to Reimbursement for Next-Generation Therapeutics Staff December 23, 2025 Brain Healthcare Hospitals News Pharmaceutical MindMaze Therapeutics: Consolidating a Global Approach to Reimbursement for Next-Generation Therapeutics Staff December 23, 2025
